Dermot P. Kelleher FMedSci is the Dean of the Faculty of Medicine and Vice-President, Health at the University of British Columbia in Vancouver, Canada. He moved to UBC in August 2015. He was subsequently appointed as UBC's inaugural Vice-President, Health in June 2018. Previously Kelleher was Dean of the Faculty of Medicine at Imperial College London. He took up this role on 1 October 2012. From 2006 until 2012 he was Head of the School of Medicine and Vice-Provost for Medical Affairs at Trinity College, Dublin. He was one of the three founders of Opsona Therapeutics in 2004; Opsona's research is primarily focused on the role of toll-like receptors (TLRs) and TLR signalling in human innate immunity.